Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Toray Licenses TRK-820 to Acologix for North America
June 27, 2005
- Pharma Industry Must Be Scrapped to Rebuild Globally Competitive One: Mr Murakami
June 27, 2005
- R&D NEWS IN BRIEF
June 27, 2005
- Mr Niwa Presents His Views on Social Security Reform in Booklet
June 27, 2005
- OTC NEWS IN BRIEF
June 27, 2005
- 20 New Kit Products Added to NHI Price List
June 27, 2005
- Half of Glaucoma Patients Lack Subjective Symptoms: Survey
June 27, 2005
- FPMAJ Announces Its 2005 Report on NHI Pricing
June 27, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 27, 2005
- Gov't Approves 2005 White Paper on Aging Society
June 27, 2005
- MEDICAL DEVICE NEWS IN BRIEF
June 27, 2005
- Generic Substitution Only Speculation at This Point: Mr Futagawa
June 27, 2005
- REGULATORY NEWS IN BRIEF
June 27, 2005
- Chugai to Establish New Strategic Marketing Unit in July
June 27, 2005
- Healthnet to Enter Chinese Market with NDA Support Business
June 27, 2005
- More Clinical Trials Needed in Japan: PFSB Director General
June 20, 2005
- REGULATORY NEWS IN BRIEF
June 20, 2005
- Forerunner Pharma Research Created by Chugai and 2 Other Firms
June 20, 2005
- JHSF Reports Results of Activities to Support Clinical Trials
June 20, 2005
- Consolidated Sales Up 0.8% for 26 Listed Pharma Companies in FY2004
June 20, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…